000 01226 a2200325 4500
005 20250516053814.0
264 0 _c20120425
008 201204s 0 0 eng d
022 _a1472-8206
024 7 _a10.1111/j.1472-8206.2011.00986.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchrör, Karsten
245 0 0 _aPharmacokinetic basis of the antiplatelet action of prasugrel.
_h[electronic resource]
260 _bFundamental & clinical pharmacology
_cFeb 2012
300 _a39-46 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdministration, Oral
650 0 4 _aCytochrome P-450 Enzyme System
_xmetabolism
650 0 4 _aHumans
650 0 4 _aPiperazines
_xpharmacokinetics
650 0 4 _aPlatelet Aggregation Inhibitors
_xpharmacokinetics
650 0 4 _aPrasugrel Hydrochloride
650 0 4 _aProdrugs
650 0 4 _aPurinergic P2Y Receptor Antagonists
_xpharmacokinetics
650 0 4 _aThiophenes
_xpharmacokinetics
700 1 _aSiller-Matula, Jolanta M
700 1 _aHuber, Kurt
773 0 _tFundamental & clinical pharmacology
_gvol. 26
_gno. 1
_gp. 39-46
856 4 0 _uhttps://doi.org/10.1111/j.1472-8206.2011.00986.x
_zAvailable from publisher's website
999 _c21136326
_d21136326